Research & Evidence | The Science Behind Sleepaxa Lenses
Published Research · Acieon Labs
The science, in the open.
We don’t ask you to take our claims on faith. Sleepaxa’s lenses are built on published, openly-citable research into how light affects the human body — from migraine photophobia to the melanopsin pathway that governs your sleep. Here’s the evidence base behind every lens.
Our published research
Published through our research division, Acieon Labs, each with an open, citable DOI:
| Research topic | What it covers |
|---|---|
| Wavelength-Selective Filtration | Why targeting specific wavelengths beats broad blocking |
| ipRGC & Melanopsin Biology | The eye’s non-visual light sensors and how they drive circadian rhythm |
| Dual-Band Lens Engineering | The architecture behind NeuroCalm FLX+ (Patent 587746) |
| Circadian Lens Design | Evening peak-blocking and melatonin protection to 560nm |
| Migraine & Photophobia | Light sensitivity in migraine and the role of FL-41 |
| Beyond Blue-Light Blocking | The limits of generic blue-light lenses |
Nine open-access research works in total, spanning photobiology, optics and circadian science.
The people behind the research
Led by optometrist and lead inventor Suraj Dubey (ORCID 0009-0003-7510-9254) with clinical advisor Dr. Monica Chaudhry — 37+ years in optometry, former faculty at AIIMS New Delhi (ORCID 0000-0002-2349-8986). Meet the team →
Grounded in the wider field
Our work builds on decades of peer-reviewed light science — from the Moran Eye Center’s foundational FL-41 research to modern circadian neuroscience on melanopsin and melatonin. We reference that science openly; we don’t claim these institutions endorse us. We claim we did our homework.
Published research and patent filings describe scientific and intellectual-property work. They do not represent medical-device approval or a claim to diagnose, treat, cure, or prevent any condition.